Cetera Trust Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cetera Trust Company's BMY Position: Q3 2026 in Review
Cetera Trust Company reduced its Bristol-Myers Squibb (BMY) stake by 61% in Q3 2026, selling an estimated $12.6K and leaving 130 shares worth $8.11K. The position accounts for ﹤0.01% of the portfolio, ranked #300.
Cetera Trust Company first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.09M in Q1 2024. 2,553 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Cetera Trust Company held 130 shares of Bristol-Myers Squibb worth $8.11K as of Q3 2026.
- Cetera Trust Company sold 200 Bristol-Myers Squibb shares in Q3 2026, an estimated $12.6K.
- Bristol-Myers Squibb made up ﹤0.01% of Cetera Trust Company's portfolio in Q3 2026, its #300 holding.
- Cetera Trust Company first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- Cetera Trust Company's Bristol-Myers Squibb position peaked at $1.09M in Q1 2024.
- 2,553 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Cetera Trust Company's 13F filing for Q3 2026, filed 9 Nov 2026.